Sequencing Therapy in the Current Treatment Landscape of Cholangiocarcinoma
Anthony El-Khoueiry, MD, provides a brief review of sequencing therapy for patients with cholangiocarcinoma in the modern treatment landscape.
Cholangiocarcinoma: Adverse-Event Management
Focused discussion on the adverse events that may occur when managing cholangiocarcinoma with targeted therapies.
An Overview of Treatment Advances in Metastatic Cholangiocarcinoma
A comprehensive review of chemotherapy and targeted agents available to treat cholangiocarcinoma throughout various lines of therapy.
Cholangiocarcinoma Management: Role of Biomarkers and Molecular Testing
Expert insight on the current role of biomarker testing and targeted therapy in cholangiocarcinoma management.
Identification and Diagnosis of Cholangiocarcinoma
Anthony El-Khoueiry, MD, reviews cholangiocarcinoma subtypes and outlines strategies in identification and diagnosis.
Future Treatment Landscape of Advanced HCC
Additional Second- and Third-Line Treatment Options in HCC
Second-Line Therapy in Advanced HCC
IMbrave150 Trial: Combination Therapy in Advanced HCC
Patient Prognosis and Risk Factors in HCC and Cirrhosis
69-Year-Old Man With Stage IV Hepatocellular Carcinoma
A 69-Year-Old Man With Stage 4 Hepatocellular Carcinoma
Anthony El-Khoueiry, MD, provides insight on the case of a 69-year-old man with stage 4 hepatocellular carcinoma and evaluates current and emerging treatment options.